Heart lung Machine Market Growth, Demand and Analysis 2034
Global Heart-lung Machine Market Growth, Size, Trends Analysis - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Aug-2025 | Report ID: MEDE2555 | Pages: 1 - 269 | Formats*: |
| Category : Medical Devices | |||
Heart lung Machine Market Introduction and Overview
According to SPER Market Research, the Global Heart-lung Machine Market is estimated to reach USD 4.99 billion by 2034 with a CAGR of 7.15%.
The report includes an in-depth analysis of the Global Heart-lung Machine Market, including market size and trends, Interface mix, Applications, and supplier analysis. The global heart-lung machine market size was valued at USD 2.5 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.15% from 2025 to 2034. The heart-lung machine, sometimes referred to as the cardiopulmonary bypass (CPB) machine, is a tool used in heart procedures to temporarily replace the heart and lungs. A number of reasons, such as the increased prevalence of cardiovascular diseases (CVD), improvements in surgical procedures, and the aging population, are anticipated to drive market growth.
By Component Insights
The segment with the highest revenue share, according to component, was oxygenators. In CPB operations, oxygenators effectively replace the lungs by removing carbon dioxide and delivering oxygen to the blood. One of the main factors propelling the market is the vital role oxygenators play in maintaining proper blood oxygenation, which in turn supports life throughout the body and its organs. As a result of this demand, the oxygenator sector has seen the launch of innovative new products. Innovative oxygenator designs and technologies are constantly being developed and introduced by manufacturers and businesses to improve patient outcomes, safety, and efficiency during CPB treatments.
By Application Insights
Based on application, the coronary artery bypass grafting (CABG) category had the largest revenue share. The growing prevalence of CVD and the growing need for bypass procedures are the main factors propelling the growth of the CPB machine market, which is largely driven by the CABG segment. By momentarily taking over the activities of the heart and lungs, CPB devices are vital instruments for supporting surgeons during CABG surgeries. The aging population, improvements in surgical procedures, and the ongoing development of CPB machine technology are further driving the market.
By End-User Insights
Due to reasons like the rising demand for heart surgeries, improvements in surgical techniques, and the growing prevalence of cardiovascular disease, the hospital's category had the biggest revenue share based on end-user. The market is growing as a result of the aging population, which raises the risk of heart valve disease and other cardiovascular disorders.
By Regional Insights
The highest revenue share came from North America. This was mostly caused by elements that contributed to the region's growth, including a high rate of heart disease, a sizable aging population, and a strong healthcare system. Every year, the nation undertakes a significant number of heart surgeries that need the use of heart-lung machines, such as valve replacements and coronary artery bypass grafting (CABG). The United States' dominant position in the industry is further supported by favorable reimbursement regulations, large R&D expenditures, and the existence of important market participants.
Market Competitive Landscape
To keep their market leadership, a number of important industry participants are advancing type innovation and strategic alliances. To create cutting-edge heart-lung devices with improved features including real-time monitoring, integration with other surgical equipment, and improved biocompatibility, businesses are heavily spending in research and development. Some of the prominent players in Global Heart-lung Machine Market are Braile Biomédica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co., Ltd), NIPRO, Technowood International Pte Ltd, among Others.
Recent Developments:
In March 2023, LivaNova declared that their Essenz heart-lung machine, which is used for cardiopulmonary bypass (CPB) surgeries, has been approved by the U.S. FDA under 510(k). Advanced cable management and components are integrated into this machine to improve clinical outcomes and provide a seamless user experience. The company was able to improve its R&D capacity and boost its income thanks to this regulatory approval.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Component, By Application, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Braile Biomédica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co, Ltd), NIPRO, Technowood International Pte Ltd. |
Key Topics Covered in the Report
- Global Heart-lung Machine Market Size (FY’2021-FY’2034)
- Overview of Global Heart-lung Machine Market
- Segmentation of Global Heart-lung Machine Market By Component, (Oxygenators, Pumps, Cannula, Monitoring Systems, Heat Exchanger Units, Blood Reservoir, Others)
- Segmentation of Global Heart-lung Machine Market By Application, (Coronary Artery Bypass Grafting, Heart Valve Surgeries, Heart Transplant, Lung Transplant, Others)
- Segmentation of Global Heart-lung Machine Market By End-User (Hospitals, Cardiac Centers, Others)
- Statistical Snap of Global Heart-lung Machine Market
- Expansion Analysis of Global Heart-lung Machine Market
- Problems and Obstacles in Global Heart-lung Machine Market
- Competitive Landscape in the Global Heart-lung Machine Market
- Details on Current Investment in Global Heart-lung Machine Market
- Competitive Analysis of Global Heart-lung Machine Market
- Prominent Players in the Global Heart-lung Machine Market
- SWOT Analysis of Global Heart-lung Machine Market
- Global Heart-lung Machine Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Heart-lung Machine Market Manufacturing Base Distribution, Sales Area, Interface Type6.2.Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Heart-lung Machine Market
7.Global Heart-lung Machine Market, By Component 2021-2034 (USD Million)
7.1.Oxygenators7.2.Pumps7.3.Cannula7.4.Monitoring Systems7.5.Heat Exchanger Units7.6.Blood Reservoir7.7.Others
8.Global Heart-lung Machine Market, By Application 2021-2034 (USD Million)
8.1.Coronary Artery Bypass Grafting (CABG)8.2.Heart Valve Surgeries8.3.Heart Transplant8.4.Lung Transplant8.5.Others
9.Global Heart-lung Machine Market, By End-User 2021-2034 (USD Million)
9.1.Hospitals9.2.Cardiac Centers9.3.Others
10.Global Heart-lung Machine Market, 2021-2034 (USD Million)
10.1.Global Heart-lung Machine Market Size and Market Share
11.Global Heart-lung Machine Market, By Region, 2021-2034 (USD Million)
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Braile Biomédica
12.1.1.Company details12.1.2.Financial outlook12.1.3.Interface summary12.1.4.Recent developments
12.2.ELITE LIFECARE
12.2.1.Company details12.2.2.Financial outlook12.2.3.Interface summary12.2.4.Recent developments
12.3.Getinge
12.3.1.Company details12.3.2.Financial outlook12.3.3.Interface summary12.3.4.Recent developments
12.4.Hemovent GmbH
12.4.1.Company details12.4.2.Financial outlook12.4.3.Interface summary12.4.4.Recent developments
12.5.LivaNova, Inc
12.5.1.Company details12.5.2.Financial outlook12.5.3.Interface summary12.5.4.Recent developments
12.6.Medtronic
12.6.1.Company details12.6.2.Financial outlook12.6.3.Interface summary12.6.4.Recent developments
12.7.MERA (Senko Medical Instrument Mfg. Co., Ltd)
12.7.1.Company details12.7.2.Financial outlook12.7.3.Interface summary12.7.4.Recent developments
12.8.NIPRO
12.8.1.Company details12.8.2.Financial outlook12.8.3.Interface summary12.8.4.Recent developments
12.9.Technowood International Pte. Ltd
12.9.1.Company details12.9.2.Financial outlook12.9.3.Interface summary12.9.4.Recent developments
12.9.5.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Heart lung Machine Market is projected to reach USD 4.99 billion by 2034, growing at a CAGR of 7.15% during the forecast period.
Heart lung Machine Market size from 2025. The Market is expected to reach USD 4.99 billion by 2034, at a CAGR of 7.15% during the forecast period.
Heart lung Machine Market CAGR of 7.15% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Heart lung Machine Market size is USD 4.99 billion from 2025 to 2034.
Heart lung Machine Market covered By Component, By Application, By End-User
The North America is anticipated to have the highest Market share in the Heart lung Machine Market.
Braile Biomédica, ELITE LIFECARE, Getinge, Hemovent GmbH, LivaNova, Inc, Medtronic, MERA (Senko Medical Instrument Mfg. Co, Ltd), NIPRO, Technowood International Pte Ltd.
The report includes an in-depth analysis of the Global Heart-lung Machine Market, including market size and trends, Interface mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
